ResMed Inc. RMD
NYSE
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 10.80% | 8.75% | 15.71% | 18.99% | 29.21% |
| Total Depreciation and Amortization | 2.26% | 3.95% | 24.88% | 14.63% | 13.08% |
| Total Amortization of Deferred Charges | -24.79% | 0.17% | -1.25% | -3.74% | -5.59% |
| Total Other Non-Cash Items | -49.09% | 14.56% | 5.45% | 27.64% | -10.22% |
| Change in Net Operating Assets | -212.09% | -543.56% | -147.13% | 196.91% | 2,116.57% |
| Cash from Operations | -5.97% | 3.10% | 14.34% | 29.68% | 30.74% |
| Capital Expenditure | -40.93% | -73.91% | -61.29% | -45.33% | -31.77% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -155.91% | -151.87% | -705.14% | -493.28% | -361.58% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -351,422.22% | -231.38% | 153.71% | -13.36% | 99.19% |
| Cash from Investing | 60.53% | -172.54% | -161.66% | -135.55% | -114.71% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -2,500.00% | 75.00% | 97.01% | 98.20% | 98.53% |
| Issuance of Common Stock | -5.80% | 0.09% | 4.68% | 13.40% | 22.76% |
| Repurchase of Common Stock | -260.35% | -126.93% | -132.18% | -114.96% | -100.27% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -11.26% | -12.47% | -11.95% | -11.46% | -10.75% |
| Other Financing Activities | -- | -- | -1,169.59% | -1,169.59% | -1,169.59% |
| Cash from Financing | -199.63% | -66.11% | -8.63% | 22.47% | 38.71% |
| Foreign Exchange rate Adjustments | -22.98% | -76.03% | 523.55% | 301.80% | 2.37% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -138.97% | -73.25% | 4.75% | 187.18% | 340.71% |